Polymeric particulates to improve oral bioavailability of peptide drugs
Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their ora...
Saved in:
Published in: | Molecules (Basel, Switzerland) Vol. 10; no. 1; pp. 65 - 80 |
---|---|
Main Authors: | , |
Format: | Journal Article Book Review |
Language: | English |
Published: |
Switzerland
MDPI AG
31-01-2005
MDPI |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed. |
---|---|
AbstractList | Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed. Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed. |
Author | Delie, Florence Blanco-Príeto, María José |
AuthorAffiliation | 1 School of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland, Phone: (+41) 22 379 6573, Fax: (+41) 22 379 6567, E-mail: Florence.Delie@pharm.unige.ch 2 Centro Galénico, Farmacia y Tecnología Farmacéutica, Universidad de Navarra; Ap. 177, 31080 – Pamplona, Spain, Phone: (+34) 948 42 56 00, Fax: (+34) 948 42 56 49 |
AuthorAffiliation_xml | – name: 1 School of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland, Phone: (+41) 22 379 6573, Fax: (+41) 22 379 6567, E-mail: Florence.Delie@pharm.unige.ch – name: 2 Centro Galénico, Farmacia y Tecnología Farmacéutica, Universidad de Navarra; Ap. 177, 31080 – Pamplona, Spain, Phone: (+34) 948 42 56 00, Fax: (+34) 948 42 56 49 |
Author_xml | – sequence: 1 givenname: Florence surname: Delie fullname: Delie, Florence email: Florence.Delie@pharm.unige.ch organization: School of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland. Florence.Delie@pharm.unige.ch – sequence: 2 givenname: María José surname: Blanco-Príeto fullname: Blanco-Príeto, María José |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/18007277$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU9r3DAQxUVJaJJtoZ-gGHrJZRONZEneS6GE_IOF5JCexVgab7V4LVe2F_bbR8lum4QRzCA9fqPHO2NHXeyIsW_AL6Rc8EvgPB-tPrFTKAWfS14ujt7NJ-xsGNacCyhBfWYnUHFuhDGn7PYxtrsNpeCKHtMY3NTiSEMxxiJs-hS3VMSEbVGHiFsMLdahDeOuiE3RUz8GT4VP02r4wo4bbAf6eugz9vvm-unqbr58uL2_-rWcOyX5OAeBKMTClZ5ACy1JV0DkFRlfl4iOUHBFHhw6j0ZrpVVTg_DGCF8jVXLG7vdcH3Ft-xQ2mHY2YrCvFzGt7KuNluwCRWU8NiRNXXqfeR5Lchwdd8YDZdbPPauf6g15R92YrX6Afnzpwh-7iluroTRK6Qz4cQCk-HeiYbTrOKUu-7egJACvcmXV-V7lUhyGRM3_DcDtS3z2X3xZ-v39j96Eh7zkM340mQw |
CitedBy_id | crossref_primary_10_1007_s12668_013_0084_7 crossref_primary_10_1517_17425247_5_1_45 crossref_primary_10_1111_apm_12351 crossref_primary_10_4103_0975_1483_83765 crossref_primary_10_1371_journal_pone_0194298 crossref_primary_10_1080_01932691003757314 crossref_primary_10_1016_j_maturitas_2012_05_014 crossref_primary_10_2165_11539070_000000000_00000 crossref_primary_10_1002_rcm_4544 crossref_primary_10_1007_s13346_021_01056_8 crossref_primary_10_1517_13543784_2010_517745 crossref_primary_10_1007_s11051_017_3901_z crossref_primary_10_1016_j_carbpol_2014_12_044 crossref_primary_10_1002_jps_21347 crossref_primary_10_1002_jemt_20529 crossref_primary_10_1177_0883911511430537 crossref_primary_10_1002_wnan_1315 crossref_primary_10_1016_j_nano_2012_07_005 crossref_primary_10_3390_molecules191117848 crossref_primary_10_1007_s11095_012_0943_x crossref_primary_10_1248_bpb_29_1790 crossref_primary_10_1016_j_ejps_2010_06_010 crossref_primary_10_3109_10717544_2014_970297 crossref_primary_10_1590_S0104_14282011005000060 crossref_primary_10_2478_v10007_007_0013_9 crossref_primary_10_1016_j_ijpharm_2010_12_010 crossref_primary_10_3109_03639045_2015_1081234 crossref_primary_10_1016_j_bbapap_2007_08_007 crossref_primary_10_1080_17425247_2018_1503249 crossref_primary_10_1080_02652040802485485 crossref_primary_10_1021_mp100253e crossref_primary_10_1080_02652040600682390 crossref_primary_10_1016_j_carbpol_2015_01_066 crossref_primary_10_1021_acs_molpharmaceut_7b00458 crossref_primary_10_4103_0253_7613_71887 crossref_primary_10_1002_jbm_a_33052 crossref_primary_10_1002_pi_2273 crossref_primary_10_1211_jpp_59_4_0002 crossref_primary_10_3390_ma16093382 crossref_primary_10_1007_s10792_013_9829_0 crossref_primary_10_3109_03639045_2013_841187 crossref_primary_10_1021_cr900327d crossref_primary_10_1039_D3BM00191A crossref_primary_10_1211_jpp_59_12_0002 crossref_primary_10_3109_10717544_2011_577108 crossref_primary_10_1016_j_addr_2017_05_004 crossref_primary_10_1088_0957_4484_21_6_065104 crossref_primary_10_1590_s1517_707620190003_0712 crossref_primary_10_1002_mabi_200700022 crossref_primary_10_1007_s11095_010_0358_5 crossref_primary_10_1016_j_ijbiomac_2014_08_053 crossref_primary_10_1016_j_jconrel_2017_09_003 crossref_primary_10_1016_j_carbpol_2020_117504 crossref_primary_10_1155_2017_5813793 crossref_primary_10_1007_s11095_007_9367_4 crossref_primary_10_1016_j_addr_2009_11_023 crossref_primary_10_1155_2017_7120815 crossref_primary_10_2217_nnm_09_110 crossref_primary_10_3109_08982104_2013_805339 crossref_primary_10_1089_jop_2011_0215 crossref_primary_10_1039_b9nr00407f crossref_primary_10_1517_17425247_2012_717068 crossref_primary_10_1016_j_drudis_2012_03_019 crossref_primary_10_1080_10611860600864182 crossref_primary_10_3390_ijms151018040 crossref_primary_10_1016_j_vaccine_2011_05_098 crossref_primary_10_1080_17435390802398309 crossref_primary_10_3109_03639045_2012_699069 crossref_primary_10_1007_s11095_008_9620_5 crossref_primary_10_1002_pola_23786 crossref_primary_10_3109_03639045_2014_947507 crossref_primary_10_2174_1573412915666190314124932 crossref_primary_10_1517_17425247_2015_1068287 crossref_primary_10_1016_j_ijpharm_2016_01_028 crossref_primary_10_1016_j_ijpharm_2014_06_035 crossref_primary_10_1016_j_colsurfb_2012_03_024 crossref_primary_10_1590_S1984_82502015000200024 crossref_primary_10_1016_j_ddtec_2008_11_005 |
Cites_doi | 10.1038/sj.bjp.0700910 10.1023/A:1015897900363 10.1046/j.1463-1326.2000.00080.x 10.1248/cpb.46.1613 10.1016/S0168-3659(96)01475-7 10.3109/10611869308996082 10.1016/0168-3659(90)90133-E 10.1136/gut.6.3.225 10.1016/0264-410X(92)90021-B 10.1023/A:1011934328471 10.1111/j.2042-7158.1990.tb07033.x 10.1021/jm00021a014 10.1111/j.2042-7158.1979.tb13510.x 10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-# 10.1006/meth.1999.0786 10.1016/0168-3659(90)90013-J 10.1016/S0378-5173(99)00118-0 10.3109/02652049609026049 10.1080/15287398009529888 10.1016/S0378-5173(99)00049-6 10.1021/js980337n 10.1159/000196856 10.1016/0168-3659(93)90190-G 10.1016/0378-5173(86)90236-X 10.1038/386410a0 10.1016/S1054-3589(08)60188-X 10.3109/03639048209022119 10.1016/0168-3659(96)01368-5 10.1016/S0378-5173(00)00627-X 10.1111/j.2042-7158.1991.tb05437.x 10.1016/0168-3659(96)01342-9 10.1023/A:1018986226557 10.1007/978-1-4684-5344-7_30 10.1023/A:1018826103261 10.1016/S0928-0987(97)10007-0 10.1016/S0169-409X(98)00042-8 10.1002/jps.2600651115 10.1016/S0939-6411(98)00064-2 10.1023/A:1007582332491 10.1159/000135938 10.3109/10611860108997924 10.1016/0169-409X(91)90048-H 10.1111/j.1749-6632.1975.tb51092.x 10.1081/DDC-100102197 10.1016/S0378-5173(02)00002-9 10.1021/jm00021a015 10.1002/jps.2600841202 10.1016/0168-3659(91)90028-C 10.1016/S0169-409X(98)00041-6 10.1023/A:1015846810474 10.1016/S0169-409X(98)00039-8 10.1016/S0169-409X(98)00045-3 10.1159/000196836 10.1023/A:1012126301290 10.1023/A:1016073416332 10.1128/iai.56.1.278-282.1988 10.3109/02652049809008242 10.1016/0378-5173(94)00104-9 10.1016/S0168-3659(00)00339-4 10.1051/parasite/1998053223 10.2337/diab.37.2.246 10.1016/S0168-3659(99)00247-3 |
ContentType | Journal Article Book Review |
Copyright | Copyright MDPI AG 2005 2005 by MDPI (http://www.mdpi.org). 2005 |
Copyright_xml | – notice: Copyright MDPI AG 2005 – notice: 2005 by MDPI (http://www.mdpi.org). 2005 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 5PM DOA |
DOI | 10.3390/10010065 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Databases ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) |
DatabaseTitleList | MEDLINE Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1420-3049 |
EndPage | 80 |
ExternalDocumentID | oai_doaj_org_article_9a287dafe37b4ddda7da4ec0ac0c7d1e 3321822561 10_3390_10010065 18007277 |
Genre | Evaluation Studies Journal Article Review |
GroupedDBID | --- 0R~ 123 2WC 3V. 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ AADQD AAFWJ AAHBH ABJCF ABUWG ACGFO ACIWK ACPRK AEGXH AENEX AFKRA AFPKN AFRAH AFZYC AIAGR ALIPV ALMA_UNASSIGNED_HOLDINGS BBNVY BENPR BHPHI BPHCQ BVXVI C1A CCPQU CGR CS3 CUY CVF D1I DIK DU5 E3Z ECM EIF ESX FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE HZ~ I09 IPNFZ KB. KQ8 LK8 M1P M7P MODMG M~E NPM O-U O9- OK1 P2P PDBOC PIMPY PQQKQ PROAC PSQYO RIG RPM TR2 UKHRP AAYXX CITATION 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 5PM |
ID | FETCH-LOGICAL-c530t-12aa229c4de16263e681eed5e7db4aacea205ed1cacda766565fb12d772dbae83 |
IEDL.DBID | RPM |
ISSN | 1420-3049 |
IngestDate | Tue Oct 22 15:08:36 EDT 2024 Tue Sep 17 20:58:32 EDT 2024 Tue Nov 19 06:07:00 EST 2024 Thu Nov 21 21:09:06 EST 2024 Sat Sep 28 08:36:44 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Reproduction is permitted for noncommercial purposes. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c530t-12aa229c4de16263e681eed5e7db4aacea205ed1cacda766565fb12d772dbae83 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147556/ |
PMID | 18007277 |
PQID | 1531108080 |
PQPubID | 2032355 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_9a287dafe37b4ddda7da4ec0ac0c7d1e pubmedcentral_primary_oai_pubmedcentral_nih_gov_6147556 proquest_journals_1531108080 crossref_primary_10_3390_10010065 pubmed_primary_18007277 |
PublicationCentury | 2000 |
PublicationDate | 20050131 |
PublicationDateYYYYMMDD | 2005-01-31 |
PublicationDate_xml | – month: 1 year: 2005 text: 20050131 day: 31 |
PublicationDecade | 2000 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Molecules (Basel, Switzerland) |
PublicationTitleAlternate | Molecules |
PublicationYear | 2005 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | Leroux (ref_63) 1995; 84 Vranckx (ref_29) 1996; 42 Kreuter (ref_8) 1976; 11 Zimmer (ref_11) 1999; 18 Eldridge (ref_62) 1990; 11 Volkheimer (ref_39) 1975; 246 Delie (ref_51) 1998; 34 Ammoury (ref_26) 1991; 8 Barichello (ref_66) 1999; 25 Volkheimer (ref_35) 1977; 14 Carino (ref_60) 2000; 65 Couvreur (ref_7) 1979; 31 Rafati (ref_13) 1997; 43 McGhee (ref_42) 1997; 10 Leroux (ref_2) 1998; 34 Couvreur (ref_5) 1995; 41 Hillery (ref_20) 1996; 42 Kim (ref_65) 1997; 120 McInnes (ref_76) 1995; 38 (ref_44) 1998; 34 Jani (ref_49) 1990; 42 Oppenheim (ref_19) 1982; 8 Fessi (ref_27) 1986; 2 LeFevre (ref_50) 1980; 6 Couvreur (ref_54) 2001; 9 Cornes (ref_36) 1965; 6 Ma (ref_61) 2000; 2 Milstein (ref_77) 1996; 13 Soppimath (ref_6) 2001; 70 Alonso (ref_4) 1996; 77 Michel (ref_23) 1988; 37 Leroux (ref_33) 1999; 16 Vonderscher (ref_58) 1997; 49 Eldridge (ref_43) 1989; 146 Volkheimer (ref_40) 1968; 1 Lowman (ref_72) 1999; 88 Lambert (ref_30) 2000; 17 Kissel (ref_16) 1991; 16 Fessi (ref_25) 1986; 28 Doelker (ref_28) 1998; 15 Michel (ref_24) 1991; 43 Magenheim (ref_31) 1991; 1 Gupta (ref_18) 1993; 26 Hubert (ref_67) 1991; 8 Orsolini (ref_17) 1999; 184 Ford (ref_22) 1999; 183 Nagareya (ref_73) 1998; 46 Jepson (ref_45) 1993; 1 Couvreur (ref_55) 1980; 26 Singh (ref_70) 1998; 15 Delie (ref_14) 2001; 214 Lescure (ref_9) 1994; 11 Volkheimer (ref_37) 1968; 1 Kreuter (ref_34) 1991; 7 Aboubakar (ref_57) 2000; 49 Beck (ref_69) 1994; 40 Delie (ref_12) 1994; 111 Wells (ref_48) 1988; 56 Watnasirichaikul (ref_59) 2002; 235 McClean (ref_46) 1998; 6 Delie (ref_52) 1996; 23 Berton (ref_10) 1999; 47 Jeurissen (ref_47) 1987; 216A Sordet (ref_64) 1998; 5 Hillery (ref_21) 1996; 41 Volkheimer (ref_38) 1968; 1 Simecka (ref_41) 1998; 34 Bruhn (ref_15) 1991; 18 Santiago (ref_75) 1995; 38 Maas (ref_68) 1997; 5 Mathiowitz (ref_74) 1997; 386 Lee (ref_1) 1988; 5 Fessi (ref_32) 1995; 5 Gurny (ref_3) 1993; 39 Leroux (ref_71) 1996; 13 Michel (ref_56) 1990; 13 Desai (ref_53) 1997; 14 |
References_xml | – volume: 120 start-page: 399 year: 1997 ident: ref_65 article-title: The Antihypertensive Effect of Orally Administered Nifedipine-Loaded Nanoparticles in Spontaneously Hypertensive Rats publication-title: Brit. J. Pharmacol. doi: 10.1038/sj.bjp.0700910 contributor: fullname: Kim – volume: 23 start-page: 149 year: 1996 ident: ref_52 article-title: Caco-2 Monolayers As a Tool to Examine Intestinal Uptake of Particulates publication-title: Proceed. Intern. Symp. Control. Rel. Bioact. Mater. contributor: fullname: Delie – volume: 8 start-page: 734 year: 1991 ident: ref_67 article-title: The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker publication-title: Pharm Res doi: 10.1023/A:1015897900363 contributor: fullname: Hubert – volume: 2 start-page: 243 year: 2000 ident: ref_61 article-title: Preliminary Study of Oral Polylactide Microcapsulated Insulin in Vitro and in Vivo publication-title: Diabetes Obes. Metab. doi: 10.1046/j.1463-1326.2000.00080.x contributor: fullname: Ma – volume: 46 start-page: 1613 year: 1998 ident: ref_73 article-title: Preparation and Characterization of Enteric Microspheres Containing Bovine Insulin by a w/o/w Emulsion Solvent Evaporation Method publication-title: Chem. Pharm. Bull. doi: 10.1248/cpb.46.1613 contributor: fullname: Nagareya – volume: 43 start-page: 89 year: 1997 ident: ref_13 article-title: Protein-Loaded Poly(DL-Lactide-Co-Glycolide) Microparticles for Oral Administration: Formulation, Structural and Release Characteristics publication-title: J. Contr. Rel. doi: 10.1016/S0168-3659(96)01475-7 contributor: fullname: Rafati – volume: 1 start-page: 245 year: 1993 ident: ref_45 article-title: Comparison of Poly(DL-Lactide-Co-Glycolide) and Polystyrene Microsphere Targeting to Intestinal M Cells publication-title: J. Drug Targ. doi: 10.3109/10611869308996082 contributor: fullname: Jepson – volume: 11 start-page: 205 year: 1990 ident: ref_62 article-title: Controlled Vaccine Release in the Gut-Associated Lymphoid Tissues. 1. Orally Administered Biodegradable Microspheres Target the Peyer's Patches publication-title: J. Contr. Rel. doi: 10.1016/0168-3659(90)90133-E contributor: fullname: Eldridge – volume: 6 start-page: 225 year: 1965 ident: ref_36 article-title: Number, Size, and Distribution of Peyer's Patches in the Human Small Intestine publication-title: Gut doi: 10.1136/gut.6.3.225 contributor: fullname: Cornes – volume: 10 start-page: 75 year: 1997 ident: ref_42 article-title: The Mucosal Immune System: From Fundamental Concepts to Vaccine Development publication-title: Vaccine doi: 10.1016/0264-410X(92)90021-B contributor: fullname: McGhee – volume: 15 start-page: 1056 year: 1998 ident: ref_28 article-title: Preparation and Characterization of Nanocapsules From Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique publication-title: Pharm.Res. doi: 10.1023/A:1011934328471 contributor: fullname: Doelker – volume: 42 start-page: 821 year: 1990 ident: ref_49 article-title: Nanoparticles Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1990.tb07033.x contributor: fullname: Jani – volume: 5 start-page: 242 year: 1995 ident: ref_32 article-title: Gastro-Intestinal Tolerance Study of a Freeze-Dried Oral Dosage Form of Indomethacin-Loaded Nanocapsules publication-title: S. T. P. Pharma Sciences contributor: fullname: Fessi – volume: 38 start-page: 4257 year: 1995 ident: ref_76 article-title: Microsphere Formation in a Series of Derivatized α-Amino Acids: Properties, Molecular Modeling, and Oral Delivery of Salmon Calcitonin publication-title: J. Med. Chem. doi: 10.1021/jm00021a014 contributor: fullname: McInnes – volume: 31 start-page: 331 year: 1979 ident: ref_7 article-title: Polycyanoacrylate Nanocapsules As Potential Lysosomotropic Carriers: Preparation, Morphological and Sorptive Properties publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1979.tb13510.x contributor: fullname: Couvreur – volume: 49 start-page: 109 year: 2000 ident: ref_57 article-title: Insulin-Loaded Nanocapsules for Oral Administration: In Vitro and in Vivo Investigation publication-title: Drug Develop. Res. doi: 10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-# contributor: fullname: Aboubakar – volume: 18 start-page: 286 year: 1999 ident: ref_11 article-title: Antisense Oligonucleotide Delivery With Polyhexylcyanoacrylate Nanoparticles As Carriers publication-title: Methods doi: 10.1006/meth.1999.0786 contributor: fullname: Zimmer – volume: 13 start-page: 233 year: 1990 ident: ref_56 article-title: Nanocapsules As Carriers for Oral Peptide Delivery publication-title: J. Contr. Rel. doi: 10.1016/0168-3659(90)90013-J contributor: fullname: Michel – volume: 41 start-page: 2 year: 1995 ident: ref_5 article-title: Controlled Drug Delivery With Nanoparticles: Current Possibilities and Future Trends publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Couvreur – volume: 184 start-page: 243 year: 1999 ident: ref_17 article-title: Importance of the Test Medium for the Release Kinetics of a Somatostatin Analogue From Poly(D,L-Lactide-Co-Glycolide) Micropheres publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(99)00118-0 contributor: fullname: Orsolini – volume: 13 start-page: 651 year: 1996 ident: ref_77 article-title: PH-Dependent Microspheres From Modified Soybean Protein Hydrolysate publication-title: J. Microencaps. doi: 10.3109/02652049609026049 contributor: fullname: Milstein – volume: 6 start-page: 691 year: 1980 ident: ref_50 article-title: Intestinal Barrier to Large Particulates in Mice publication-title: J. Toxicol. Env. Health. doi: 10.1080/15287398009529888 contributor: fullname: LeFevre – volume: 183 start-page: 3 year: 1999 ident: ref_22 article-title: Nanospheres of Cyclosporin A: Poor Oral Absorption in Dogs publication-title: Int J Pharm doi: 10.1016/S0378-5173(99)00049-6 contributor: fullname: Ford – volume: 88 start-page: 933 year: 1999 ident: ref_72 article-title: Oral Delivery of Insulin Using pH-Responsive Complexation Gels publication-title: J. Pharm. Sci. doi: 10.1021/js980337n contributor: fullname: Lowman – volume: 5 start-page: 69 year: 1988 ident: ref_1 article-title: Enzymatic Barriers to Peptide and Protein Absorption publication-title: CRC Crit. Rev. Ther. Drug Carrier Syst. contributor: fullname: Lee – volume: 1 start-page: 213 year: 1968 ident: ref_38 article-title: The Phenomenon of Persorption publication-title: Digestion doi: 10.1159/000196856 contributor: fullname: Volkheimer – volume: 26 start-page: 229 year: 1993 ident: ref_18 article-title: In Vitro and in Vivo Evaluation of Clarithromycin/Poly(Lactic Acid) Microspheres for Intramuscular Drug Delivery publication-title: J. Contr. Rel. doi: 10.1016/0168-3659(93)90190-G contributor: fullname: Gupta – volume: 28 start-page: 125 year: 1986 ident: ref_25 article-title: Development of a New Process for the Manufacture of Polyisobutylcyanoacrylate Nanocapsules publication-title: Int. J. Pharm doi: 10.1016/0378-5173(86)90236-X contributor: fullname: Fessi – volume: 386 start-page: 410 year: 1997 ident: ref_74 article-title: Biologically Erodable Microspheres As Potential Oral Drug Delivery Systems publication-title: Nature doi: 10.1038/386410a0 contributor: fullname: Mathiowitz – volume: 14 start-page: 163 year: 1977 ident: ref_35 article-title: Persorption of Particles: Physiology and Pharmacology publication-title: Adv. Pharmaco. Chemother. doi: 10.1016/S1054-3589(08)60188-X contributor: fullname: Volkheimer – volume: 8 start-page: 531 year: 1982 ident: ref_19 article-title: The Production and Evaluation of Orally Administred Insulin Nanoparticles publication-title: Drug Dev. Ind. Pharm. doi: 10.3109/03639048209022119 contributor: fullname: Oppenheim – volume: 42 start-page: 65 year: 1996 ident: ref_20 article-title: Co-Polymerised Peptide Particles (CPP) II: Oral Uptake of a Novel Co-Polymeric Nanoparticulate Delivery System for Peptides publication-title: J. Control. Rel. doi: 10.1016/0168-3659(96)01368-5 contributor: fullname: Hillery – volume: 214 start-page: 25 year: 2001 ident: ref_14 article-title: Comparison of Two Methods of Encapsulation of an Oligonucleotide into Poly(D,L-Lactic Acid) Particles publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(00)00627-X contributor: fullname: Delie – volume: 43 start-page: 1 year: 1991 ident: ref_24 article-title: The Effect of Site of Administration in Gastrointestinal Tract on the Absorption of Insulin From Nanocapsules in Diabetic Rats publication-title: J. Pharm. Pharmacol. doi: 10.1111/j.2042-7158.1991.tb05437.x contributor: fullname: Michel – volume: 5 start-page: 171 year: 1997 ident: ref_68 article-title: Improved Body Distribution of 14C-Labelled AZT Bound to Nanoparticles in Rats Determined by Radioluminography publication-title: J. Drug Targ. contributor: fullname: Maas – volume: 41 start-page: 271 year: 1996 ident: ref_21 article-title: Co-Polymerised Peptide Particles (CPP) I: Synthesis, Charaterisation and in Vitro Studies on a Novel Oral Nanoparticulate Delivery System publication-title: J. Control. Rel. doi: 10.1016/0168-3659(96)01342-9 contributor: fullname: Hillery – volume: 42 start-page: 345 year: 1996 ident: ref_29 article-title: A New Nanocapsule Formulation With Hydrophilic Core: Application to the Oral Administration of Salmon Calcitonin in Rats publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Vranckx – volume: 11 start-page: 1270 year: 1994 ident: ref_9 article-title: Preparation and Characterization of Novel Poly(Methylidene Malonate 2.1.2.)-Made Nanoparticles publication-title: Pharm. Res doi: 10.1023/A:1018986226557 contributor: fullname: Lescure – volume: 216A start-page: 257 year: 1987 ident: ref_47 article-title: The Role of Peyer's Patches in Intestinal Humoral Immune Responses Is Limited to Memory Formation publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-1-4684-5344-7_30 contributor: fullname: Jeurissen – volume: 16 start-page: 859 year: 1999 ident: ref_33 article-title: Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and in Vitro Cell Uptake publication-title: Pharm. Res. doi: 10.1023/A:1018826103261 contributor: fullname: Leroux – volume: 6 start-page: 153 year: 1998 ident: ref_46 article-title: Binding and Uptake of Biodegradable Poly-DL-Lactide Micro- and Nanoparticles in Intestinal Epithelia publication-title: Eur. J. Pharm. Sci. doi: 10.1016/S0928-0987(97)10007-0 contributor: fullname: McClean – volume: 26 start-page: 220 year: 1980 ident: ref_55 article-title: Oral and Parenteral Administration of Insulin Associated to Hydrolysable Nanoparticles publication-title: Acta Pharm. Technol. contributor: fullname: Couvreur – volume: 34 start-page: 235 year: 1998 ident: ref_41 article-title: Mucosal Immunity of the Gastrointestinal Tract and Oral Tolerance publication-title: Adv. Drug Del. Rev. doi: 10.1016/S0169-409X(98)00042-8 contributor: fullname: Simecka – volume: 11 start-page: 1624 year: 1976 ident: ref_8 article-title: In Vitro Studies of Poly(Methyl Methacrylate) Adjuvants publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600651115 contributor: fullname: Kreuter – volume: 40 start-page: 134 year: 1994 ident: ref_69 article-title: Improved Peroral Delivery of Avarol With Polybutylcyanoacrylate Nanoparticles publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Beck – volume: 47 start-page: 119 year: 1999 ident: ref_10 article-title: Uptake of Oligonucleotide-Loaded Nanoparticles in Prostatic Cancer Cells and Their Intracellular Localization publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/S0939-6411(98)00064-2 contributor: fullname: Berton – volume: 17 start-page: 707 year: 2000 ident: ref_30 article-title: Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core As a Novel Colloidal Carrier for the Delivery of Oligonucleotides publication-title: Pharm.Res. doi: 10.1023/A:1007582332491 contributor: fullname: Lambert – volume: 1 start-page: 8 year: 1968 ident: ref_40 article-title: The Effect of Drugs on the Rate of Persorption publication-title: Pharmacology doi: 10.1159/000135938 contributor: fullname: Volkheimer – volume: 9 start-page: 141 year: 2001 ident: ref_54 article-title: In Vitro and in Vivo Evaluation of Poly(Methylidene Malonate 2.1.2) Microparticles Behavior for Oral Administration publication-title: J. Drug Target. doi: 10.3109/10611860108997924 contributor: fullname: Couvreur – volume: 39 start-page: 173 year: 1993 ident: ref_3 article-title: Drug Loaded Nanoparticles - Preparation Methods and Drug Targeting Issues publication-title: Eur. J. Pharm. Biopharm. contributor: fullname: Gurny – volume: 7 start-page: 71 year: 1991 ident: ref_34 article-title: Peroral Administration of Nanoparticles publication-title: Adv. Drug Del. Rev. doi: 10.1016/0169-409X(91)90048-H contributor: fullname: Kreuter – volume: 246 start-page: 164 year: 1975 ident: ref_39 article-title: Hematogenous Dissemination of Ingested Polyvinyl Chloride Particles publication-title: Proceed. Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1975.tb51092.x contributor: fullname: Volkheimer – volume: 25 start-page: 471 year: 1999 ident: ref_66 article-title: Encapsulation of Hydrophilic and Lipophilic Drugs in PLGA Nanoparticles by the Nanoprecipitation Method publication-title: Drug Dev. Ind. Pharm. doi: 10.1081/DDC-100102197 contributor: fullname: Barichello – volume: 235 start-page: 237 year: 2002 ident: ref_59 article-title: Effect of Formulation Variables on Characteristics of Poly(Ethylcyanoacrylate) Nanocapsules Prepared From W/o Microemulsions publication-title: Int. J. Pharm. doi: 10.1016/S0378-5173(02)00002-9 contributor: fullname: Watnasirichaikul – volume: 38 start-page: 4263 year: 1995 ident: ref_75 article-title: N-Acylated α-Amino Acids As Novel Oral Delivery Agents for Proteins publication-title: J. Med. Chem. doi: 10.1021/jm00021a015 contributor: fullname: Santiago – volume: 84 start-page: 1388 year: 1995 ident: ref_63 article-title: Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles Following Intravenous and Oral Administration to Mice publication-title: J. Pharm. Sci. doi: 10.1002/jps.2600841202 contributor: fullname: Leroux – volume: 16 start-page: 27 year: 1991 ident: ref_16 article-title: Parenteral Depot-Systems on the Basis of Biodegradable Polyesters publication-title: J. Contr. Rel. doi: 10.1016/0168-3659(91)90028-C contributor: fullname: Kissel – volume: 34 start-page: 221 year: 1998 ident: ref_51 article-title: Evaluation of Nano- and Microparticle Uptake by the Gastrointestinal Tract publication-title: Adv. Drug Del. Rev. doi: 10.1016/S0169-409X(98)00041-6 contributor: fullname: Delie – volume: 8 start-page: 101 year: 1991 ident: ref_26 article-title: Jejunal Absorption, Pharmacological Activity, and Pharmacokinetic Evaluation of Indomethacin-Loaded Poly(DL-Lactide) and Poly(Isobutyl-Cyanoacrylate) Nanocapsules in Rats publication-title: Pharm. Res. doi: 10.1023/A:1015846810474 contributor: fullname: Ammoury – volume: 34 start-page: 171 year: 1998 ident: ref_2 article-title: Polymeric Nano- and Microparticles for the Oral Delivery of Peptides and Peptidomimetics publication-title: Adv. Drug Del. Rev. doi: 10.1016/S0169-409X(98)00039-8 contributor: fullname: Leroux – volume: 34 start-page: 305 year: 1998 ident: ref_44 article-title: Microparticles and Polymers for the Mucosal Delivery of Vaccines publication-title: Adv. Drug Del. Rev. doi: 10.1016/S0169-409X(98)00045-3 – volume: 1 start-page: 78 year: 1968 ident: ref_37 article-title: Persorption of Particles publication-title: Digestion doi: 10.1159/000196836 contributor: fullname: Volkheimer – volume: 14 start-page: 1568 year: 1997 ident: ref_53 article-title: The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent publication-title: Pharm. Res. doi: 10.1023/A:1012126301290 contributor: fullname: Desai – volume: 13 start-page: 485 year: 1996 ident: ref_71 article-title: pH-Sensitive Nanoparticles: an Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitor in Dogs publication-title: Pharm. Res. doi: 10.1023/A:1016073416332 contributor: fullname: Leroux – volume: 56 start-page: 278 year: 1988 ident: ref_48 article-title: Evidence for the Phagocytic Transfer of Intestinal Particles in Dogs and Rats publication-title: Infect. Immun. doi: 10.1128/iai.56.1.278-282.1988 contributor: fullname: Wells – volume: 15 start-page: 581 year: 1998 ident: ref_70 article-title: Methotrexate Loaded Chitosan and Chitin Microspheres - in Vitro Characterization and Pharmacokinetics in Mice Bearing Ehrlich Ascite Carcinoma publication-title: J. Microencaps. doi: 10.3109/02652049809008242 contributor: fullname: Singh – volume: 111 start-page: 137 year: 1994 ident: ref_12 article-title: Characterization of V3BRU Peptide Loaded Small PLGA Microspheres Prepared by (W1/O)W2 Emulsion Solvent Evaporation publication-title: Int. J. Pharm. doi: 10.1016/0378-5173(94)00104-9 contributor: fullname: Delie – volume: 77 start-page: 203 year: 1996 ident: ref_4 article-title: Nanoparticulate Drug Carrier Technology publication-title: Drugs Pharm. Sci. contributor: fullname: Alonso – volume: 70 start-page: 1 year: 2001 ident: ref_6 article-title: Biodegradable Polymeric Nanoparticles As Drug Delivery Devices publication-title: J. Control. Release doi: 10.1016/S0168-3659(00)00339-4 contributor: fullname: Soppimath – volume: 5 start-page: 223 year: 1998 ident: ref_64 article-title: Assessment of the Activity of Atovaquone-Loaded Nanocapsules in the Treatment of Acute and Chronic Murine Toxoplasmosis publication-title: Parasite doi: 10.1051/parasite/1998053223 contributor: fullname: Sordet – volume: 49 start-page: 949 year: 1997 ident: ref_58 article-title: Poly(Alkyl Cyanoacrylate) Nanocapsules As a Delivery System in the Rat for Octreotide, a Long-Acting Somatostatin Analogue publication-title: J. Pharm. Pharmacol. contributor: fullname: Vonderscher – volume: 37 start-page: 246 year: 1988 ident: ref_23 article-title: New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules As Drug Carrier publication-title: Diabetes doi: 10.2337/diab.37.2.246 contributor: fullname: Michel – volume: 18 start-page: 668 year: 1991 ident: ref_15 article-title: Preparation and Characterization of Spray-Dried Poly(Dl-Lactide) Microspheres publication-title: Proceed. Int. Symp. Contr. Rel. Bioact. Mater. contributor: fullname: Bruhn – volume: 65 start-page: 261 year: 2000 ident: ref_60 article-title: Nanospheres Based Oral Insulin Delivery publication-title: J. Contr. Rel. doi: 10.1016/S0168-3659(99)00247-3 contributor: fullname: Carino – volume: 146 start-page: 59 year: 1989 ident: ref_43 article-title: Biodegradable Microspheres: Vaccine Delivery System for Oral Immunization publication-title: Curr. Top. Microbiol. Immunol. contributor: fullname: Eldridge – volume: 1 start-page: 221 year: 1991 ident: ref_31 article-title: Nanoparticle Characterization: a Comprehensive Physicochemical Approach publication-title: S.T.P.Pharma contributor: fullname: Magenheim – volume: 2 start-page: 608 year: 1986 ident: ref_27 article-title: Procédé De Préparation De Systèmes Colloïdaux Dispersibles D'Une Substance, Sous Forme De Nanoparticules publication-title: Brevet français contributor: fullname: Fessi |
SSID | ssj0021415 |
Score | 2.1843808 |
SecondaryResourceType | review_article |
Snippet | Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 65 |
SubjectTerms | Administration, Oral Animals Biological Availability calcitonin Gastrointestinal Tract - drug effects Gastrointestinal Tract - metabolism Humans insulin Intestinal Absorption - drug effects mechanisms of absorption microparticle Models, Biological Nanoparticle Nanoparticles - administration & dosage Nanoparticles - chemistry oral route Particle Size peptide Peptides - administration & dosage Peptides - pharmacokinetics Pharmaceutical Preparations - administration & dosage Polymers - chemical synthesis Polymers - chemistry Polymers - pharmacokinetics protein Review |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ1LT4QwEMcb3YtejG_R1dTEK1laCoWj-3JPuomaeCOlndVNNovZh8l-e6cFVteYeDGcoAkZZoD5D7S_IeRGpREHjc-3iETsizRO_dRo4aOYCMJQhTLJ7drhwaO8f0m6PYvJWbf6snPCSjxw6bhWqlDTGzWCUObCGKNwR4AOlA60NAzc2zeQdTFVlVpMuN4FTNj1wSiCS-xsiAV-y0KHbOLdSESO1_-byPw5V_Jb8unvk71KNdLb0toDsgXTQ7LTqZu1HZG7YTFZuZ8vdOiuyXblgjldFLT8bAD0Ac9L2-NCfajxpKRzr2gxokM7r8UA7c6Wr_Nj8tzvPXUGftUjwddRGCx8xpXiPNXCALNgGYgThmkvAmlyoZQGxYMIDNNKo-tiVG_RKGfcoKg2uYIkPCGNaTGFM0IDAzwZcTBSCAEcFMuxGLGIKWORO9Ij17XDsvcShZFhCWGdmtVO9UjbenI9buHV7gCGNKtCmv0VUo806zhk1RM1z_DNbFcs4OaR0zIkX1YkFoAu0UK5EawNMzZHpuM3x9JGdSKjKD7_D7svyK4DuwYMM1uTNBazJVyS7blZXrm78xMEcuwB priority: 102 providerName: Directory of Open Access Journals |
Title | Polymeric particulates to improve oral bioavailability of peptide drugs |
URI | https://www.ncbi.nlm.nih.gov/pubmed/18007277 https://www.proquest.com/docview/1531108080 https://pubmed.ncbi.nlm.nih.gov/PMC6147556 https://doaj.org/article/9a287dafe37b4ddda7da4ec0ac0c7d1e |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Nb9QwEIZHbC9wQXyTtlRG4ppu7NhxcqTbll6AlQCJW-R4ZstK26TaD6T--46dBFjECeWWKNFoxs7Mm4wfA7xzlVHkeX5ro4tUV0WVVuh1ysVElucut2UT1g5ffbGfvpfnFwGTY8a1MLFp3zfL03Z1c9ouf8TeytsbPx37xKbzjzNOKdaYYjqBCdeGo0QfVJbklNRTZnPW89PAGAp5NtBBy8DJtnYvBUVS_7_Ky7-7JP9IO5dP4PFQL4r3vV1P4QG1z-DhbNym7Tl8mHeru_jbRcyj9WE_LtqIbSf6DwYkPvNzxdmycz_dctVzue9EtxDz0NGCJM7Xu-vNC_h2efF1dpUOuyOk3uTZNpXKOaUqr5FkQMpQUUpOeIYsNto5T05lhlB659HZgus2s2ikQi6nsXFU5i_hoO1aeg0iQ1LlQhFarTUpcrJhGRLgUhhgOzaBt6PD6tseglGzeAj-rUf_JnAWPPnresBWxxPd-roegldXjgUaugXlttGIbBc6TT5zPvMWJSVwPMahHubSpuZ3clirwEcCr_qQ_LZiCGkCdi9Ye2bsX-FBFSnawyA6_O87j-BR5LhmkhPZMRxs1zt6A5MN7k6isj-J4_IeKdHo_g |
link.rule.ids | 230,314,315,729,782,786,794,866,887,2107,27932,27934,27935,53802,53804 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Lb9QwEIdHfRzKBSjPQGmNxDXd2LHj5Ei3j61oy0oUiVvk2LNlpW1S7QOp_z1jJwEW9VTlFivRyD87MxOPPwN8MoUSaGl-SyWzWBZZERfOypiCiSRNTarzyu8dHn3TVz_y4xOPyVH9XphQtG-r6WE9uz2spz9DbeXdrR30dWKD8eWQXIpWKhtswjbN10T0SXqXZ3FySi1nNqWMfuApQ97Tej5o7knZWq85ocDqfyjA_L9O8h_Hc_rskSY_h6ddpMk-t827sIH1C9gZ9ge8vYSzcTO7Dws2bBxe4k_ywgVbNqz91YDsK9nDjqaN-WWms5bofc-aCRv7WhiH7Hi-ulm8gu-nJ9fDUdydqxBblSbLmAtjhCisdMg9jAaznJOrVKhdJY2xaESi0HFrrDM6o4hPTSouHAXirjKYp69hq25qfAsscSjyiUCnpZQo0PCKEhiPpXIe06Mj-Nh3dHnX4jNKSju8LmWvSwRHXoE_7R54HW4085uy68OyMJTaOTPBVFfSObLLGYk2MTax2nGMYK_Xr-xm4aKkr7nf5UBXBG9aKf9a0Q2FCPSayGtmrLeQtoG_3Wn57tFPHsDO6Pryorw4v_ryHp4EGmzCyR3uwdZyvsIPsLlwq_0wqn8DimT9lQ |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB3RIgGX8k0DBYzENU3sOHFypLtdioASCZC4RY5nUlbaJqv9QOq_x3aSwiJOoNziJBr5efJmkvEbgNe6SAUZ698ylVkoi6wICzQytMFEnCQ6UXnt9g6ffVbn3_LpqZPJuW715Yv2TT0_bheXx-38u6-tXF6aaKwTi8qPE0spKk2zaIlNtAc3rc_GckzUh1yLW2LqtWYTm9VHTmnIsa3TCM2dWrZSO0Tk9fr_FmT-WSv5G_nM7v6H2ffgYIg42Zv-kvtwg9oHcHsyNnp7CG_LbnHlf9yw0j_IdfSiNdt0rP_kQOyTtYmdzDv9Q88XvbL3FesaVrqaGCQ2XW0v1o_g6-z0y-QsHPorhCZN4k3IhdZCFEYicSdKQ1nOLWWmpLCWWhvSIk4JudEGtcps5Jc2NRdoA3KsNeXJY9hvu5YOgcVIIm8EoZJSkiDNa5vIOHkqdHI9KoBX42RXy15Go7Lph8OmGrEJ4MShcD3uhK_9iW51UQ3zWBXapnioG0pULRGtXaglmVib2CjkFMDRiGE1eOO6sm91t9vBHgE86eH8ZcWwHAJQO0DvmLE7YvH1OtwDnk__-c6XcKuczqoP787fP4M7XhQ25pYVj2B_s9rSc9hb4_aFX9g_AX1dACQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polymeric+Particulates+to+Improve+Oral+Bioavailability+of+Peptide+Drugs&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Delie%2C+Florence&rft.au=Blanco-Pr%C3%ADeto%2C+Mar%C3%ADa+Jose&rft.date=2005-01-31&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=10&rft.issue=1&rft.spage=65&rft_id=info:doi/10.3390%2F10010065&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3321822561 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon |